Metraipolis › archive › dc_2b8b62a67ac9

A preliminary study to evaluate efficacy and safety of Lugol's solution following radioiodine for remnant ablation in differentiated thyroid cancer — Europe PMC PMID:41821880

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41821880
DOI
10.3389/fonc.2026.1783763
License (as archived)
solo-consultazione
Archived
2026-11-05T08:00:42.822Z
SHA-256 of the archived text
0a56a52b49889719718aa1fa5a6c3f264836ed4115294f78aaee9974c41c42f6
Stable URL of this page
https://metraipolis.com/documento/dc_2b8b62a67ac9

How to cite

A preliminary study to evaluate efficacy and safety of Lugol's solution following radioiodine for remnant ablation in differentiated thyroid cancer — Europe PMC PMID:41821880 — Europe PMC (en), https://europepmc.org/article/MED/41821880 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2b8b62a67ac9 (Metraipolis archive dc_2b8b62a67ac9, sha256 0a56a52b49889719718aa1fa5a6c3f264836ed4115294f78aaee9974c41c42f6)
BibTeX
@misc{dc2b8b62a67ac9,
  title = {A preliminary study to evaluate efficacy and safety of Lugol's solution following radioiodine for remnant ablation in differentiated thyroid cancer — Europe PMC PMID:41821880},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41821880},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2b8b62a67ac9; sha256 0a56a52b49889719718aa1fa5a6c3f264836ed4115294f78aaee9974c41c42f6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41821880. Agents can read the archived copy with the MCP tool read_document.